Journals / Clinical and Experimental Health Sciences / 2015 / Cilt: 5 - Sayı: 3

The role of endothelin-1 and new therapeutic approaches in sepsis and septic shock

Sepsis ve septik şok patojenezinde endotelin-1’in rolü ve tedavide yeni yaklaşımlar

Pages
178–190
Publication Date
2015-10-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mitogen-activated protein kinase signal transduction pathway is stimulated by ET-1 which activates a variety of downstream molecules; it is believed that ET-1could play an important role in the development of sepsis, septic shock, and multiple organ dysfunction syndrome by events that can cause increased reactive oxygen species (ROS) production, inflammation, endothelial dysfunction, abnormal vascular tonus, and vascular remodelling.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:As a systemic inflammatory response to infection, sepsis describes a complex clinical syndrome that results in progressively advance stage, probably evoke septic shock, multiple organ dysfunction syndrome and ultimately cause to death.
📊
Key Findings & Data:In 1988, endothelin (ET)-1 was identified as a vasoactive amine from endothelium which has a 21 amino acid peptide.
💡
Conclusion & Impact:Mitogen-activated protein kinase signal transduction pathway is stimulated by ET-1 which activates a variety of downstream molecules; it is believed that ET-1could play an important role in the development of sepsis, septic shock, and multiple organ dysfunction syndrome by events that can cause increased reactive oxygen species (ROS) production, inflammation, endothelial dysfunction, abnormal vascular tonus, and vascular remodelling.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Endotelin-1 · sepsis · septik şok

Abstract

As a systemic inflammatory response to infection, sepsis describes a complex clinical syndrome that results in progressively advance stage, probably evoke septic shock, multiple organ dysfunction syndrome and ultimately cause to death. Sepsis is markedly enhanced by proinflammatory cytokines that can trigger a systemic inflammatory cascade mediated by chemokines, vasoactive amines, complement and coagulation system as well as reactive oxygen species (ROS). In 1988, endothelin (ET)-1 was identified as a vasoactive amine from endothelium which has a 21 amino acid peptide. It has been demonstrated with the experimental and clinical studies that endothelin acts as an important role in sepsis and septic shock pathogenesis. Moreover, endothelin receptor antagonists have been studied as novel therapeutic target for treatment of sepsis and septic shock and according to these studies beneficial results have been obtained . Mitogen-activated protein kinase signal transduction pathway is stimulated by ET-1 which activates a variety of downstream molecules; it is believed that ET-1could play an important role in the development of sepsis, septic shock, and multiple organ dysfunction syndrome by events that can cause increased reactive oxygen species (ROS) production, inflammation, endothelial dysfunction, abnormal vascular tonus, and vascular remodelling.

Özet

Vücuda giren patojene karşı gelişen sistemik enflamatuvar yanıt olarak adlandırılan sepsis, septik şok, çoklu organ yetmezliği ve ölümle sonuçlanabilmektedir. Sistemik enflamatuvar yanıtı tetikleyebilen artmış proenflamatuvar sitokin düzeyleriyle birlikte kemokinler, koagülasyon ve kompleman sistemleri ile vazoaktif aminler de sepsis patojenezinde yer almaktadır. Endotelin (ET)-1, 1988 yılında vazoaktif amin olarak damar endotelinden izole edilmiş olup 21 zincirli amino asit zincirine sahip bir peptitdir. (ET)-1’in sepsis ve septik şok gelişimindeki rolü deneysel ve klinik çalışmalarda gösterilmiş olup, reseptör antagonistleri sepsis tedavisinde denenmiş ve yararlı sonuçlar sağlamıştır. ET-1’in mitojenle etkinleştirilen protein kinaz sinyal ileti yolunu uyararak etkinleştirdiği downstream sinyal molekülleri aracılığıyla reaktif oksijen türlerinin üretiminde artış, enflamasyon gelişimi, endotelyal işlevde bozulma, anormal damar gerimi ve damarlarda yeniden modellenme gibi olaylara yol açarak sepsis, septik şok ve çoklu organ yetmezliği gelişiminde önemli rolü olabileceği düşünülmektedir.

🔖

Cite This Article

Güden, D. S., Temiz, M., Tunçtan, B., Fırat, S. Ş. (2015). The role of endothelin-1 and new therapeutic approaches in sepsis and septic shock. Clinical and Experimental Health Sciences, Cilt: 5 - Sayı: 3, 178–190. https://ajindex.com/articles/481773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Carré JE, Singer M. Cellular energetic metabolism in sepsis: the need for a systems approach. Biochim Biophys Acta. 2008;1777:763-771.
  2. Fernandes D, Assreuy J. Nitric oxide and vascular reactivity in sepsis. Shock. 2008;30:10-13.
  3. Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit. 2005;11:76-85.
  4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest. 1992;101(6):644-655. Kayaalp O. Otakoidler. Akılcı Tedavi Yönünden Tıbbi Farmakoloji. 13. Baskı. İstanbul: Güneş Tıp Kitabevi; 2012. s. 130-135.
  5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
  6. Aygen B, Kayabaş Ü, Güven M, Doğanay M, Sümerkan B, Yıldız O. Erciyes Üniversitesi Tıp Fakültesi yoğun bakım üniteleri nozokomial infeksiyonları sürveyansı: Epidemioloji, risk faktörleri ve prognozu etkileyen faktörler. Yoğun Bakım Dergisi. 2001;1:122-30.
  7. Tunctan B, Korkmaz B, Sari AN, Kacan M, Unsal D, Serin MS, Buharalioglu CK, Sahan-Firat S, Schunck WH, Falck JR, Malik KU. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid. Antiinflamm Antiallergy Agents Med Chem. 2012;11(2):121-150.
  8. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344- 353. Dipiro JT, Talbert LR, Yee GC, Matzke GR,Wells GB, Posey ML. Sepsis and septic shock. Pharmacotherapy. 7th Ed. USA: McGraw-Hill Companies; 2008. p.1943-55. Ünsal D. Sıçanlarda Zimosan ile Oluşan Hipotansiyona Dalak Tirozin Kinazının Katkısının Araştırılması. Mersin Üniversitesi Sağlık Bilimleri Enstitüsü; 2013.
  9. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365:63-78.
  10. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002;71:635-700.
  11. Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988;57:505- 518. Miller SI, Ernst RK, Bade